# EDGAR Filing Document

**Accession Number:** 0001000228
**File Stem:** 0001000228-25-000066
**Filing Date:** 2025-11
**Character Count:** 26253
**Document Hash:** 51b080d6ef7701a38000abe32fd9f560
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001000228-25-000066.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0001000228-25-000066

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 94

**CONFORMED PERIOD OF REPORT**: 20250927

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HENRY SCHEIN INC
- **CENTRAL INDEX KEY:** 0001000228
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 113136595
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1227

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-27078
- **FILM NUMBER:** 251448176

**BUSINESS ADDRESS:**
- **STREET 1:** 135 DURYEA RD
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747
- **BUSINESS PHONE:** 6318435500

**MAIL ADDRESS:**
- **STREET 1:** 135 DURYEA RD
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCHEIN HENRY INC
- **DATE OF NAME CHANGE:** 19950907

## Exhibit 10.1

#### Exhibit 10.1

#### Execution

#### CONFIDENTIAL
November 4, 2025

#### VIA E-MAIL
Henry Schein, Inc.

135 Duryea Road

Melville, New York 11747

Attention: Kelly Murphy

Email:[ \*\*\* - personal information]

KKR Hawaii Aggregator L.P.

c/o Kohlberg Kravis Roberts & Co. L.P.

Sand Hill Road, Suite 200

Menlo Park, CA 94025

Attention: Hunter Craig and Max Lin

Email: [\*\*\* - personal information]

#### Re: Amendment No. 1 to Strategic Partnership Agreement (this "Amendment")
Ladies and Gentlemen:

Reference is made to the Strategic Partnership Agreement, dated as of January 29, 2025

(as heretofore amended or modified, the "Agreement"), by and between Henry Schein, Inc., a

Delaware corporation (the "Company"), on the one hand, and KKR Hawaii Aggregator L.P., a

Delaware limited partnership (the "Investor"), on the other hand. Capitalized terms used but not

defined in this Amendment shall have the meanings ascribed to them in the Agreement. The

parties, intending to be legally bound, agree to amend the Agreement as follows:

1. Restriction on Business Combinations. The parties hereby consent and agree to

amend and restate Section 3.15 of the Agreement in its entirety as follows:

"Section 3.15 Restriction on Business Combinations. The Board has taken all action

necessary to render inapplicable to the Investor Parties the restrictions on "business

combinations" set forth in Section 203 of the DGCL ("Section 203") in connection with

the Investor Parties' becoming an "interested stockholder" (as defined in Section 203) of

the Company by acquiring an aggregate of 15% or more of the outstanding voting stock of

the Company, whether by (i) direct or indirect beneficial ownership of stock; (ii) the right

to acquire stock (whether such right is exercisable immediately or only after the passage of

time) pursuant to any agreement, arrangement or understanding, or upon the exercise of

conversion rights, exchange rights, warrants or options, or otherwise; (iii) the right to vote

stock pursuant to any agreement, arrangement or understanding; provided, however, the

agreement, arrangement or understanding to vote such stock does not arise solely from a

revocable proxy or consent given in response to a proxy or consent solicitation made to 10

or more Persons; or (iv) any agreement, arrangement or understanding for the purpose of

acquiring, holding, voting (other than voting pursuant to a revocable proxy or consent given

in response to a proxy or consent solicitation made to 10 or more Persons), or disposing of

stock with any other Person that beneficially owns, or whose Affiliates or associates

beneficially own, directly or indirectly, such stock."

2. Standstill. The parties hereby consent and agree to amend and restate Section 5.08

of the Agreement in its entirety as follows:

"Section 5.08 Standstill. Each Investor Party agrees with the Company, severally and not

jointly, that, during the Term and thereafter until the date occurring six (6) months after

the earliest date following the Term on which no Investor Director is serving on the Board,

without the prior written approval of the Board, such Investor Party and its controlled

Affiliates shall not, directly or indirectly:

(a) acquire, offer or seek to acquire, agree to acquire or make a proposal

to acquire, whether by private or open market purchase, a block trade, a tender or

exchange offer, beneficial ownership of, or any economic interest in, any right to

direct the voting or disposition of, or any other right with respect to any Voting

Securities or direct or indirect rights to acquire any Voting Securities of the

Company, any securities convertible into or exchangeable for any such Voting

Securities, any options puts, calls, swaps or other derivative or convertible

instruments, hedging contracts or other derivative securities or contracts or

instruments in any way related to the price of shares of Common Stock (solely to

the extent that, after giving effect to such acquisition, such Investor Party and its

Affiliates would beneficially own, in the aggregate, greater than 19.9% of the then

outstanding Common Stock);

(b) make any public announcement with respect to, or offer, seek,

propose or indicate an interest in (in each case with or without conditions), either

alone or in concert with others, any Extraordinary Transaction, or enter into any

discussions, negotiations, arrangements, understandings (whether written or oral)

with any Person regarding any of the foregoing (it being understood that the

foregoing shall not restrict any Investor Parties from tendering shares, receiving

payment or shares or otherwise participating in any such Extraordinary Transaction

on the same basis as other stockholders of the Company);

(c) (i) make or in any way encourage or participate in any "solicitation"

of "proxies" or consents (whether or not relating to the election or removal of

directors), as such terms are used in the rules of the SEC (but without regard to the

exclusion set forth in Rule 14a-1(l)(2)(iv)), to vote, or knowingly seek to advise,

encourage or influence any Person with respect to voting, acquisition or disposition

of, any Voting Securities of the Company or any of its Subsidiaries or any securities

convertible or exchangeable into or exercisable for any such Voting Securities, (ii)

request, call or seek to call (or, for the avoidance of doubt, publicly support another

Person's request or call for) a meeting of the Company's stockholders or action by

written consent (or the setting of a record date therefor), (iii) initiate or be the

proponent of any stockholder proposal for action by the Company's stockholders,

(iv) seek, alone or in concert with others, election to or to place a representative on

the Board or nominate or propose the nomination of, or recommend the nomination

of, any candidate to the Board, except as expressly set forth in Section 5.10, (v)

seek, alone or in concert with others (including through any "withhold" or similar

campaign), the removal of any director from the Board (other than, in the case of

the Investor Parties, any Investor Directors), or (vi) become a "participant" in any

contested "solicitation" (as such terms are defined or used under the Exchange Act)

for the election of directors with respect to the Company; provided, however, that

nothing in this Agreement will prevent the Investor Parties or their Affiliates from

taking actions in furtherance of identifying any replacement for an Investor Director

pursuant to Section 5.10, as applicable;

(d) except as expressly permitted by this Agreement with respect to the

Investor Directors, otherwise act, alone or in concert with others, to seek to control

or influence, in any manner, the management, board of directors or business of the

Company or any of its Subsidiaries, including (i) controlling or changing the Board

or management of the Company, including any plans or proposals to change the

number or term of directors or to fill any vacancies on the Board, (ii) any material

change in the capitalization, capital allocation policy or dividend policy of the

Company or (iii) seeking to have the Company waive or make amendments or

modifications to the Company Charter Documents, or other actions that may

impede or facilitate the acquisition of control of the Company by any Person;

(e) grant any proxy, consent or other authority to vote any Voting

Securities with respect to any matters (other than to the named proxies included in

the Company's proxy card for any annual meeting or special meeting of

stockholders);

(f) agree, attempt, seek or propose to deposit any shares of Common

Stock in any voting trust or similar arrangement or subject any shares of Common

Stock to any arrangement or agreement with respect to the voting of any shares of

Common Stock, other than any such voting trust, arrangement or agreement solely

among such Investor Party and its controlled Affiliates and otherwise in accordance

with this Agreement;

(g) other than sales into the public market pursuant to a bona fide,

broadly distributed underwritten public offering, in each case made pursuant to the

Registration Rights Agreement or through a bona fide sale to the public without

registration effectuated pursuant to Rule 144 under the Securities Act where the

identity of the purchaser is not known, sell, offer or agree to sell, directly or

indirectly, through swap or hedging transactions or otherwise, the securities of the

Company or any rights decoupled from the underlying securities of the Company

held by such Investor Party to any Third Party that, to the actual knowledge of such

Investor Party, would result in such Third Party, together with its Affiliates,

owning, controlling or otherwise having any beneficial or other ownership interest

representing in the aggregate in excess of 4.9% of the shares of Common Stock

outstanding at such time or would increase the beneficial or other ownership

interest of any Third Party who, together with its Affiliates, has a beneficial or other

ownership interest in the aggregate of more than 4.9% of the shares of Common

Stock outstanding at such time; provided, that the restriction in this Section 5.08(g)

will not apply with respect to any Third Party who makes filings with respect to the

Company's securities to the SEC on Schedule 13G pursuant to Rule 13d-1(b) under

the Exchange Act;

(h) make a request for any stockholder list or other Company books and

records under Section 220 of the DGCL or otherwise; provided that nothing in this

Agreement shall restrict any Investor Director's rights as a director of the Company

under Section 220(d) of the Delaware General Corporation Law;

(i) make any proposal or statement of inquiry or disclose any intention,

plan or arrangement inconsistent with any of the foregoing;

(j) advise, assist, knowingly encourage or direct any Person to do, or to

advise, assist, knowingly encourage or direct any other Person to do, any of the

foregoing;

(k) enter into any agreements, arrangements or understandings with any

Third Party (including security holders of the Company, but excluding, for the

avoidance of doubt, any Investor Party and its Affiliates) with respect to any of the

foregoing, including forming, joining or in any way participating in a "group" (as

defined in Section 13(d)(3) of the Exchange Act) with any Third Party in

connection with any of the foregoing;

(l) request the Company or any of its Representatives, directly or

indirectly, to amend or waive any provision of this Section 5.08; provided that this

clause shall not prohibit any Investor Party from making a confidential request to

the Company seeking an amendment or waiver of the provisions of this Section

5.08, which the Company may accept or reject in its sole discretion, so long as any

such request is made in a manner that does not require public disclosure thereof by

any Person; or

(m) contest the validity of this Section 5.08 or make, initiate, take or

participate in any demand, Action (legal or otherwise) or proposal to amend, waive

or terminate any provision of this Section 5.08.

The restrictions in this Section 5.08 shall terminate automatically upon the earliest

occurrence of any of the following: (A) the Company's entry into a definitive agreement

with respect to any Extraordinary Transaction that would result in the acquisition by any

person or group of more than 50% of the Voting Securities or assets having an aggregate

value exceeding 50% of the aggregate enterprise value of the Company and (B) the

commencement of any tender or exchange offer (by any Person or group other than the

Investor Parties or their Affiliates) which, if consummated, would constitute an

Extraordinary Transaction that would result in the acquisition by any person or group (with

the exception of the Investor Parties and any of their Affiliates) of more than 50% of the

Voting Securities, where the Company files with the SEC a Schedule 14D-9 (or

amendment thereto) that does not recommend that its stockholders reject such tender or

exchange offer.

Notwithstanding anything to the contrary contained in this Agreement, nothing the

Agreement shall limit the ability of any Investor Director to vote or otherwise exercise his

or her legal duties or otherwise act in his or her capacity as a member of the Board.

Furthermore, notwithstanding anything to the contrary in this Section 5.08, nothing in this

Section 5.08 shall prohibit or restrict the Investor Parties from: (A) communicating

privately with the Board, any member of senior management of the Company (including

the Company's Chief Executive Officer, Chief Financial Officer, and General Counsel) or

any director of the Company regarding any matter (it being understood that the Investor

Parties shall not engage in any such private communications if the content of such

communications would reasonably be expected to require any public disclosure of such

communications, without the prior authorization of the Board or Chief Executive Officer);

(B) privately communicating to the Investor Parties' or its Affiliates' investors or potential

investors regarding the Company; provided that any such communications to investors or

potential investors (1) are subject to reasonable confidentiality obligations of such investors

or potential investors and are not reasonably expected to be publicly disclosed, (2) are not

made with an intent to, and do not, circumvent any of the restrictions in this Agreement or

otherwise in bad faith and (3) are not intended to, and would not reasonably be expected

to, require any public disclosure of such communications; (C) making any factual statement

to comply with any subpoena or other legal process or respond to a request for information

from any Governmental Authority with jurisdiction over such Person from whom

information is sought, in each case upon the advice of outside legal counsel (provided, that,

to the extent permitted by applicable law, the applicable Investor Party will provide the

Company with notice of any such requirement prior to making any such statement); (D)

voting, transferring or hedging (subject to Section 5.08(g) and Section 5.20); (E)

participating in rights offerings made by the Company to all holders of its Common Stock,

receiving any dividends or similar distributions with respect to any securities of the

Company held by such Investor Party, tendering shares of Common Stock, or otherwise

exercising rights under its Common Stock that are not the subject of this Section 5.08; or

(F) at any time after eight months following the date hereof, making a proposal relating to

an Extraordinary Transaction, provided that such proposal is first made privately to the

Board or Chief Executive Officer and is conditioned on the approval of the Board."

3. Entire Agreement; Amendment. The Agreement, together with the other

Transaction Documents and this Amendment, contains the entire understanding of the Parties with

respect to the subject matter hereof or thereof. Any previous agreements among the Parties relating

to the specific subject matter hereof are superseded by the Agreement and this Amendment. All

references to the "Agreement" in the Agreement shall refer to the Agreement as amended by this

Amendment.

4. No Other Modifications. This Amendment shall only amend the Agreement as

expressly set forth herein. All other terms of the Agreement shall remain in full force and effect.

5. The provisions of Article VIII of the Agreement are hereby incorporated by

reference into this Amendment, mutatis mutandis.

*[Signature Page Follows]*

[

*Signature Page to Amendment No. 1*

]

If the terms of this Amendment are in accordance with your understanding, please sign

below and this Amendment will constitute a binding agreement among us.

#### HENRY SCHEIN, INC.
By: /s/ Kelly Murphy

Name: Kelly Murphy

Title: Senior Vice President and General Counsel

Acknowledged and Agreed:

#### KKR HAWAII AGGREGATOR L.P.
By: KKR Hawaii Aggregator GP LLC, its general partner

By: /s/ Max Lin

Name: Max Lin

Title: President

## Exhibit 31.1

#### EXHIBIT 31.1

#### CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES

#### EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

#### SARBANES-OXLEY ACT OF 2002
I, Stanley M. Bergman, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Henry Schein, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such

statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,

fairly present in all material respects the financial condition, results of operations and cash flows of the

registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure

controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control

over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and

have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures

to be designed under our supervision, to ensure that material information relating to the registrant,

including its consolidated subsidiaries, is made known to us by others within those entities,

particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial

reporting to be designed under our supervision, to provide reasonable assurance regarding the

reliability of financial reporting and the preparation of financial statements for external purposes in

accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this

report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end

of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that

occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the

case of an annual report) that has materially affected, or is reasonably likely to materially affect, the

registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of

directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over

financial reporting which are reasonably likely to adversely affect the registrant's ability to record,

process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a

significant role in the registrant's internal control over financial reporting.

Date: November 4, 2025

/s/ Stanley M. Bergman

Stanley M. Bergman

Chairman and Chief Executive Officer

## Exhibit 31.2

#### EXHIBIT 31.2

#### CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES

#### EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

#### SARBANES-OXLEY ACT OF 2002
I, Ronald N. South, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Henry Schein, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such

statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,

fairly present in all material respects the financial condition, results of operations and cash flows of the

registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure

controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control

over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and

have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures

to be designed under our supervision, to ensure that material information relating to the registrant,

including its consolidated subsidiaries, is made known to us by others within those entities,

particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial

reporting to be designed under our supervision, to provide reasonable assurance regarding the

reliability of financial reporting and the preparation of financial statements for external purposes in

accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this

report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end

of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that

occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the

case of an annual report) that has materially affected, or is reasonably likely to materially affect, the

registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of

directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over

financial reporting which are reasonably likely to adversely affect the registrant's ability to record,

process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a

significant role in the registrant's internal control over financial reporting.

Date: November 4, 2025

/s/ Ronald N. South

Ronald N. South

Senior Vice President and

Chief Financial Officer

## Exhibit 32.1

#### EXHIBIT 32.1

#### CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

#### AS ADOPTED PURSUANT TO SECTION 906 OF THE

#### SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report on Form 10-Q of Henry Schein, Inc. (the "Company") for the period

ending September 27, 2025, as filed with the Securities and Exchange Commission on the date hereof (the

"Report"), I, Stanley M. Bergman, the Chairman and Chief Executive Officer of the Company, and I, Ronald

N. South, Senior Vice President and Chief Financial Officer of the Company, do hereby certify pursuant to

18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of

my knowledge and belief that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act

of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and

results of operations of the Company.

/s/ Stanley M. Bergman

Dated: November 4, 2025

Stanley M. Bergman

Chairman and Chief Executive Officer

Dated: November 4, 2025

/s/ Ronald N. South

Ronald N. South

Senior Vice President and

Chief Financial Officer

This certification accompanies each Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and

shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company

for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has

been provided to the Company and will be retained by the Company and furnished to the Securities and

Exchange Commission or its staff upon request.